# Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease

> **NCT00719849** · PHASE2 · TERMINATED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** fludarabine phosphate
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** umbilical cord blood transplantation
- **RADIATION:** total body irradiation

## Key facts

- **NCT ID:** NCT00719849
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2008-11
- **Final completion:** 2009-12
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** A new protocol was developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719849, "Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00719849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*